Status
Global HQ
Boston, United States
Countries of investment
Investment stages
Industries
About
NYBC Ventures is a $50 million venture fund committed to fostering innovation in blood-related and cellular medicines and technologies. With a strategic focus on therapeutics, medical devices, and cutting-edge technologies, NYBC Ventures aims to tackle pressing challenges in benign hematology, infectious diseases, and transfusion medicine. By partnering with visionary entrepreneurs and groundbreaking startups, the fund seeks to accelerate the development of transformative solutions that can significantly enhance patient care and outcomes in the hematology space. Through its investments, NYBC Ventures is not only driving financial returns but also contributing to the advancement of healthcare solutions that can improve the quality of life for patients worldwide.
NYBC Ventures is a $50 million venture fund committed to fostering innovation in blood-related and cellular medicines and technologies. With a strategic focus on therapeutics, medical devices, and cutting-edge technologies, NYBC Ventures aims to tackle pressing challenges in benign hematology, infectious diseases, and transfusion medicine. By partnering with visionary entrepreneurs and groundbreaking startups, the fund seeks to accelerate the development of transformative solutions that can significantly enhance patient care and outcomes in the hematology space. Through its investments, NYBC Ventures is not only driving financial returns but also contributing to the advancement of healthcare solutions that can improve the quality of life for patients worldwide.
Investment Thesis
Manager's Experience
With extensive experience in the venture capital landscape, the fund manager has successfully executed over 50 deals across various sectors, including technology, healthcare, and consumer products. Active in both North America and Europe, their strategic style combines an operator-first approach with a data-driven analysis to identify high-potential startups. Notable exits in their portfolio demonstrate their ability to capitalize on emerging trends and foster growth in early-stage investments. The emphasis on thematic investing reflects a commitment to innovation and long-term value creation.
NYBC Ventures Contacts Information
Primary contact